Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates
The Manila Times - 05 May 2025Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates ...
phase 2a
Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates ...
Panama City reaches milestone in Harrison Avenue Streetscape Project. Part of road reopens
Panama City News Herald - 05 May 2025Panama City reaches milestone in Harrison Avenue Streetscape Project. Part of road reopens ...
Immuneering Corp SEC 10-Q Report
TradingView - 05 May 2025Immuneering Corp SEC 10-Q Report ...
Inmagene Reports Topline Results from Phase 2a Study of
GlobeNewswire - 24 Apr 2025Inmagene Reports Topline Results from Phase 2a Study of ...
Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025
Business Wire - 24 Mar 2025Kezar Life Sciences to Present Topline Results from the PORTOLA Phase 2a Trial Evaluating Zetomipzomib for the Treatment of Patients with Autoimmune Hepatitis on March 25, 2025 ...
Ekovest gets govt approval for two links connecting to Duke Expressway
The Edge Malaysia - 05 May 2025Ekovest gets govt approval for two links connecting to Duke Expressway ...
(PDF) A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer
ResearchGate - 22 Oct 2024(PDF) A phase 2a clinical study on the safety and efficacy of individualized dosed mebendazole in patients with advanced gastrointestinal cancer ...
Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting
The Manila Times - 23 Apr 2025Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting ...
Aplagon secures EUR 7 million for APAC phase 2a trials
PharmaTimes - 03 Feb 2025Aplagon secures EUR 7 million for APAC phase 2a trials ...
Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology
PR Newswire - 12 Mar 2025Rivus Pharmaceuticals Announces Publication of Phase 2a HuMAIN Trial of HU6 in Patients with Obesity-Related Heart Failure in JAMA Cardiology ...
A Phase 2a Double-Blind, Placebo-Controlled, Randomized Clinical Trial Evaluating the Efficacy and Safety of NuGel, a Novel Topical GPCR19-Mediated Inflammasome Inhibitor, in Patients with Mild to Moderate Atopic Dermatitis: A Proof-of-Concept Study wi
Frontiers - 21 Apr 2025A Phase 2a Double-Blind, Placebo-Controlled, Randomized Clinical Trial Evaluating the Efficacy and Safety of NuGel, a Novel Topical GPCR19-Mediated Inflammasome Inhibitor, in Patients with Mild to Moderate Atopic Dermatitis: A Proof-of-Concept Study wi ...
Lipella Reports Positive Phase 2a Results from Second
GlobeNewswire - 22 Apr 2025Lipella Reports Positive Phase 2a Results from Second ...
Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial
PR Newswire - 15 Apr 2025Hoth Therapeutics Announces Positive Initial Data in Phase 2a Clinical Trial ...
EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week® 2025
The Manila Times - 28 Apr 2025EnteroBiotix Announces Oral Presentation of Phase 2a IBS-C Results at Digestive Disease Week® 2025 ...
Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus
GlobeNewswire - 08 Apr 2025Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus ...
Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus
GlobeNewswire - 11 Feb 2025Lipella Pharmaceuticals Reports Positive Topline Phase 2a Results for LP-310 in the Treatment of Oral Lichen Planus ...
Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
The Manila Times - 24 Apr 2025Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients ...
InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904
GlobeNewswire - 20 Dec 2024InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904 ...
NeOnc Technologies Holdings, Inc. Expects Full
GlobeNewswire - 14 Apr 2025NeOnc Technologies Holdings, Inc. Expects Full ...